Navigation Links
FDA approves VYVANSE, first and only once-daily prodrug stimulant to treat ADHD in adults
Date:4/23/2008

Basingstoke, U.K. and Philadelphia, PA April 23, 2008 Shire plc (LSE: SHP, NASDAQ: SHPGY,), the global specialty biopharmaceutical company, today announced that it has received approval from the U.S. Food and Drug Administration (FDA) for VYVANSE (lisdexamfetamine dimesylate), for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in adults. VYVANSE, introduced in July 2007 for the treatment of ADHD in children aged 6 to 12 years, is now the first and only once-daily prodrug stimulant approved to treat adults with ADHD. In its first eight months of availability, more than one million VYVANSE prescriptions have been filled.

We are very pleased with this FDA approval of the adult indication for VYVANSE, said Matthew Emmens, Chief Executive Officer of Shire. This approval provides physicians a new treatment option that can help their adult patients by significantly improving their ADHD symptoms. VYVANSE has been well accepted by the medical community. With Shires experience as a leader in the development and commercialization of ADHD medications, we are confident that this approval for adult patients will help continue to increase prescription share and volume of VYVANSE.

Many people may think of ADHD as only a childhood disorder but the fact is that the majority of children diagnosed with ADHD still have symptoms as an adult. These symptoms can significantly impact them at work, home and in relationships, where they have important responsibilities, said David W. Goodman, assistant professor of psychiatry and behavioral sciences at Johns Hopkins University School of Medicine and director of the Adult Attention Deficit Disorder Center of Maryland. The good news is that in a clinical study with adults, one daily dose of VYVANSE significantly improved ADHD symptoms of inattention, such as the ability to focus and organize, as well as hyperactivity and impulsivity.

Since VYVANSE became available for children with ADHD in
'/>"/>

Contact: Matthew Cabrey, Shire
484-595-8248
Porter Novelli
Source:Eurekalert

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. FDA Approves First Anti-Psychotic for Kids
2. FDA Approves New Roche West Nile Virus Blood Screening Test
3. FDA Approves Osteoporosis Drug to Cut Breast Cancer Risk
4. FDA Approves LEVAQUIN(R) Short-Course Therapy for Treatment of Complicated Urinary Tract Infections and Acute Pyelonephritis
5. FDA Approves SOMA(R) (carisoprodol) 250 mg
6. FDA Approves Expanded Label for FluMist(R) to Include Children Two to Five Years of Age
7. FDA approves expanded label for FluMist (influenza virus vaccine live, intranasal) to include childr
8. FDA Approves Expanded Labeling for Campath(R) to Include First-line Treatment for Leading Form of Adult Leukemia
9. ABIH Approves Certification Credit for SSPC Training Courses
10. FDA Approves REALIZE(TM) Adjustable Gastric Band for Morbid Obesity
11. FDA Approves New Flu Vaccine

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)... Leading U.S. air ambulance company no...EURAMI accreditation and Department of Defense app...PRWEB) November 9, 2009 -- AirMed International, t...oday it has earned full accreditation from the Eur...a Stuttgart, Germany, based non-profit association...
(Date:11/9/2009)...K, Nov. 9 Davis Bregman , a pai...e calls to residents of Manhattan in New York City... by calling the office at 212-918-1629 or sendin...ence of being able to see the doctor in the less s... this new way of seeing most patients. The servic...
(Date:11/8/2009)...TON, Nov. 8 Jon O,Brien...llowing statement about the passage of HR 3962: ,...erican voters a lot about core values. We in the p... seeking to overcome the struggles ordinary Americ...at many cannot afford basic healthcare or have to ...
(Date:11/8/2009)... UCW Academy of Health holds open hous...ctoria, BC (Vocus) November 8, 2009 -- UCW Academy...r in British Columbia’s health care industry...ay, November 25, 2009. , ,UCW Academy of Health, ...ion, nursing and social services, designs its prog...
(Date:11/8/2009)... New book called "Preventing and ...r. Roberto Giraldo shows that AIDS is a result of ...ty of so-called immune system stressor agents, whi...nd most of all, emotional. , ...Nov. 6 – 8, 2009, cell biologists, physician...
Breaking Medicine News(10 mins):Health News:AirMed International, Top U.S. Air Ambulance, Receives EURAMI Accreditation 2Health News:Davis Bregman MD Now Offering House Calls in Manhattan 2Health News:Catholics for Choice Statement on Healthcare Reform Bill 2Health News:College Invites Public to Explore Career Options in Health Care 2Health News:Revolutionary New Views on AIDS Highlight the Rethinking AIDS 2009 Congress; Emotional Issues can be a Significant Contributing Factor 2Health News:Revolutionary New Views on AIDS Highlight the Rethinking AIDS 2009 Congress; Emotional Issues can be a Significant Contributing Factor 3
... The more overweight children are, the poorer qual...ing to a new study.// Nearly 2,000 children par...th-related quality of life using a short survey co...he children studied were not overweight; about 20 ...
... A new study shows a clear link between fast food ..., suggesting that // fast food increases the risk ...estigated the association between reported fast fo... that changes in fast food frequency over 15 years...
... A new study shows men who consume three or more a...stroke. An ischemic stroke develops // when an art... Researchers studied more than 38,000 participan...mic stroke among the study participants. Results o...
... Moderate physical exercise can significantly redu... heart disease in older adults //, say researchers...revious cardiovascular disease, between ages 55 an...ics. The other half only received a booklet encour...
... The wet form of macular degeneration represents a... Age-related macular degeneration is the leading c... 50 years of age and older. // Two new studies sho...centers in the United States, Canada, Europe, Isra...
... High blood sugar, or hyperglycemia, is a common p...f whether they are diabetic or not.// The conditio...insulin resistance, impaired glucose metabolism, v...nvestigated more than 1,800 consecutive patients a...
Other Medicine News:
(Date:11/6/2009)...Mass., Nov. 6 Facet Solutions, Inc...assets of Archus Orthopedics. The acquisition crea...fferings, intellectual property and clinical exper... win for patients suffering from lumbar spinal ste...O, Geoff Pardo. "This consolidation further stren...
(Date:11/6/2009)...anitoba, Nov. 6 With his proposed ...s set his sights on cutting name-brand prescriptio...ho fall into the "Part D" coverage gap, universall...bout the potential cost-cutting and feel it,s a pr...he most powerful lobbyists want a revised program ...
(Date:11/6/2009)...v. 6 GeoVax Labs, Inc. ...any"), an Atlanta-based, biopharmaceutical company...HIV-1 (Human Immunodeficiency Virus) and other inf...2009 financial results and provided an operational...d Chief Executive Officer commented, "We are pleas...
Breaking Medicine Technology:Facet Solutions Acquires Archus Orthopedics 2Obama Healthcare Reforms Fall Short, but Betterthanmedicare.com Closes the 'Donut Hole' 2Obama Healthcare Reforms Fall Short, but Betterthanmedicare.com Closes the 'Donut Hole' 3GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 2GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 3GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 4GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 5GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 6GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 7GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 8ReBuilder Medical Technologies Inc Announces First Quarter 2009 is Profitable 55336 1ReBuilder Medical Technologies Inc Announces First Quarter 2009 is Profitable 55336 2Amgen Announces Top Line Results of Trial to Reduce Cardiovascular Events With Aranesp 28R 29 Therapy 28TREAT 29 in CKD Patients With Type 2 Diabetes 4898 1Amgen Announces Top Line Results of Trial to Reduce Cardiovascular Events With Aranesp 28R 29 Therapy 28TREAT 29 in CKD Patients With Type 2 Diabetes 4898 2Amgen Announces Top Line Results of Trial to Reduce Cardiovascular Events With Aranesp 28R 29 Therapy 28TREAT 29 in CKD Patients With Type 2 Diabetes 4898 3Amgen Announces Top Line Results of Trial to Reduce Cardiovascular Events With Aranesp 28R 29 Therapy 28TREAT 29 in CKD Patients With Type 2 Diabetes 4898 4Amgen Announces Top Line Results of Trial to Reduce Cardiovascular Events With Aranesp 28R 29 Therapy 28TREAT 29 in CKD Patients With Type 2 Diabetes 4898 5Amgen Announces Top Line Results of Trial to Reduce Cardiovascular Events With Aranesp 28R 29 Therapy 28TREAT 29 in CKD Patients With Type 2 Diabetes 4898 6Amgen Announces Top Line Results of Trial to Reduce Cardiovascular Events With Aranesp 28R 29 Therapy 28TREAT 29 in CKD Patients With Type 2 Diabetes 4898 7Amgen Announces Top Line Results of Trial to Reduce Cardiovascular Events With Aranesp 28R 29 Therapy 28TREAT 29 in CKD Patients With Type 2 Diabetes 4898 8HPV Vaccine Could Prevent Many Penile Cancers 55330 1HPV Vaccine Could Prevent Many Penile Cancers 55330 2
...(TM) HBSAG Test Found to Have Higher Sensitivity a...FirstVue(TM) ,...and was the preferred ... SPRINGS, Fla., Oct. 13 AT First Diagnostic LLC a...gnostic test kits, today,announced that a recent e...ute of Research of the FirstVue(TM) HBSAG Test, wa...
...n of Genomic DNA from Multiple Cancer Populations ...dies, ANN ARBOR, Mich., Oct. 13 Rubicon Genomics...erick to amplify DNA samples for The,Cancer Atlas ... amplify and standardize total genomic,DNA from 3,... The Rubicon,GenomePlex(TM) Whole Genome Amplifica...
Other Medicine Technology:Walter Reed Evaluation Concludes FirstVue(TM) HBSAG Test is Preferred over Other Rapid Tests 2Walter Reed Evaluation Concludes FirstVue(TM) HBSAG Test is Preferred over Other Rapid Tests 3Walter Reed Evaluation Concludes FirstVue(TM) HBSAG Test is Preferred over Other Rapid Tests 4Rubicon Provides Genome Amplification for the Cancer Genome Atlas Project 2Rubicon Provides Genome Amplification for the Cancer Genome Atlas Project 3
Pefakit TDT
Pefakit PiCT Controls LMWH
Pefakit TAFI Calibrator/Control
QuikCoag Control 3
Medicine Products: